REGN — REGENERON PHARMACEUTICALS

Ownership history in Quantbot Technologies LP  ·  30 quarters on record

This page tracks every 13F SEC filing in which Quantbot Technologies LP reported a position in REGENERON PHARMACEUTICALS (REGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.84% (2015 Q3)
Avg. % of fund
0.14%
First filed
2014 Q2
Last filed
2025 Q3
Quarters held
30
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 405 -902 -69.0% 0.01% $228K $560.89
2025 Q2 REDUCED 1,307 -457 -25.9% 0.02% $686K $522.92
2025 Q1 ADDED 1,764 +1,236 +234.1% 0.04% $1.1M $630.78
2024 Q4 ADDED 528 +384 +266.7% 0.01% $376K $707.55
26 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    REGN price (monthly, adj. close)

Other funds also holding REGN

As of 2025 Q4 — sorted by position size

Bronte Capital Management Pty Ltd. 3Y 7Y 13.61% Catawba River Capital 3Y 10.08% MCDONALD CAPITAL INVESTORS INC/CA 3Y 7Y 9.86% RK Asset Management, LLC 3Y 7Y 9.22% Orion Investment Co 7.25% SOUTHEASTERN ASSET MANAGEMENT INC/TN/ 3Y 7Y 5.7% GuoLine Advisory Pte Ltd 4.78% Bronte Capital Management Pty Ltd. 3Y 7Y 4.57% Rhenman & Partners Asset Management AB 3Y 7Y 4.43% SOUND SHORE MANAGEMENT INC /CT/ 3Y 7Y 4.32%
← Back to Quantbot Technologies LP Holdings